Advertisement

Reactions Weekly

, Volume 1694, Issue 1, pp 66–66 | Cite as

Atezolizumab

Leukoderma, vitiligo and halo nevi: case report
Case report
  • 24 Downloads

Reference

  1. Birnbaum MR, et al. Development of halo nevi in a lung cancer patient: A novel immune-related cutaneous event from atezolizumab. Journal of Drugs in Dermatology 16: 1047-1049, No. 10, 1 Oct 2017. Available from: URL: https://www.ncbi.nlm.nih.gov/pubmed/29036261 - USAPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations